Medical device expiration date: unknown, no lot # provided, (b)(6).A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.Device manufacture date: unknown.
|
Investigation summary: dhr review: a review of the dhr could not be performed as no batch number was provided for this incident.Qn database review: not required for level a investigation.Eura review: the defective unit was not returned for evaluation and testing; therefore root cause of the defect is indeterminate.Based on the customer's verbatim description, the effect of the defect was two or more piv insertions.Rm5769 rev 13(l) nexiva a-eura identifies ballooned tubing as a failure mode and two or more piv insertions as an effect with limited severity of s2.Occurrence of the defect could not be established for this batch as no lot number was provided.However, with low occurrence (=100 ipm) and limited severity, the risk to the end user is acceptable.Investigation conclusion: sample analysis - examination of the photos submitted by the customer show a nexiva unit with evidence of ballooned extension tubing.The customer's experience was confirmed by the photo.Root cause is indeterminate.Occlusion of the fluid pathway (e.G.Occluded catheter, kinked tubing, pinch clamp engaged during infusion) will increase the internal pressure of the unit and can cause the extension tubing to break, balloon, and/or burst.D16123 rev6(c) nexiva dual port instructions for use advises that measures should be taken to avoid kinking or obstructing the catheter system during power injection to avoid product failure.Burst or ballooning damage to the tubing can also occur if infusion is not performed correctly or performed at a psi/flow rate above the recommendations listed in d16123 rev6(c) nexiva dual port instructions for use.
|